IPV
8
1
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
Rwanda Digital Dashboard Hybrid Type 3 Implementation Study
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
Strength for U in Relationship Empowerment
Wearable Technology and Alcohol-Facilitated Intimate Partner Violence
Implementation Science and Impact Evaluation of PfR Programme: A Hybrid cRCT Design
Stepping Stones and Creating Futures Intervention Trial
HERrespect Evaluation
ID Administration of fIPV Using Intradermal Adapters vs. BCG Syringe